Skip to search.
 TSX Up 0.14% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Dyax Corp. (DYAX)

-NasdaqGM
6.64 0.19(2.78%) Apr 15, 4:00PM EDT
Add to Portfolio
Prev Close:6.83
Open:6.84
Bid:N/A
Ask:9.50 x 100
1y Target Est:13.36
Beta:1.07
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:6.15 - 6.94
52wk Range:2.26 - 10.99
Volume:3,368,323
Avg Vol (3m):1,608,020
Market Cap:837.07M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Mar-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-7.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback